Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: J Immunother. 2013 Feb;36(2):133–151. doi: 10.1097/CJI.0b013e3182829903

Figure 2.

Figure 2

Persistence of MAGE-A3 TCR post-infusion. Shown are the FACS density dot plots from patients PBMC isolated approximately one-month post-infusion. Scatter plots depict CD3+ and murine MAGE -A3 TCR beta chain expression on lymphoid cells, with the percentages of positive cells indicated in each quadrant. muTCR, murine beta chain TCR.